Home
Exact Diagnostics

Exact Diagnostics Market Share Analysis for May 2026

bio-rad is a global leader in developing and manufacturing a wide range of products for the life science research and clinical diagnostic markets.

Industry: N/A

Domainexactdiagnostics.com

Year Founded2015

Employees5001 - 10000

Annual Revenue$2M - $5M

Exact Diagnostics

Exact Diagnostics (including company regionals)

exactdiagnostics.com

See more website traffic and engagement information

Exact Diagnostics Revenue up to May 2026 is 2M - 5M

revenue generated by Exact Diagnostics top domains

Exact Diagnostics top domains revenue over 3 years

Revenue for Exact Diagnostics top domains

exactdiagnostics.com2M - 5M

See more with Sales Intelligence

Total visits to Exact Diagnostics's top domains

Understand Exact Diagnostics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Exact Diagnostics's top domains

Analyze Exact Diagnostics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Exact Diagnostics's top domains

See how Exact Diagnostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Exact Diagnostics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Exact Diagnostics

These are the website technologies, by industry, used by Exact Diagnostics top domains

Conversion & Analytics (7)

Google Analytics

Marketing (4)

Google Marketing Platform

Advertising (2)

DoubleClick

Audio Video Media (2)

Vimeo

More Technologies

6

See all

News & Signals from Exact Diagnostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsExactdiagnostics launches EDX RP Positive Run Control.Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Exact Diagnostics, a company that Bio-Rad acquired in the third quarter of 2019, has launched EDX RP Positive Run Control, an unassayed external quality control intended to monitor the performance of clinical respiratory assays.

NewsBio-Rad Laboratories, Inc. acquired Exactdiagnostics for $60M on Feb 1st '20.Bio-Rad Laboratories, in February 2020, acquired Exact Diagnostics of Fort Worth.

NewsExactdiagnostics launches SARS CoV-2 Standard.Exact Diagnostics has launched a SARS CoV-2 Standard to support laboratory assay validation of coronavirus testing, the company announced.